Lanthanum carbonate prevents accelerated medial calcification in uremic rats: role of osteoclast-like activity [PDF]
Che Yu +5 more
openalex +1 more source
Objective To observe the treatment efficiency of hemodialysis combined with hemoperfusion and oral lanthanum carbonate for uremic pruritus.Methods Twenty-one patients with uremic pruritus attending blood purification room in Wuhan Third Hospital from ...
WANG You +4 more
doaj
Background/Aims: Hyperphosphatemia is common in patients on hemodialysis. The efficacy of lanthanum carbonate (LC) in the treatment of hyperphosphatemia in these patients remains controversial.
Fang Wang +5 more
doaj +1 more source
Patients with chronic kidney disease undergoing haemodialysis have a maximum recommended dietary phosphate (P) intake of 1000 mg/day and a recommended protein intake of 1.2 g/kg/day.
J Brian Copley, Jamie Heise
doaj +1 more source
A 47-Year-Old Man with Hyperphosphatemia Due to Chronic Renal Failure Treated with Lanthanum Carbonate Tablets Presenting Acutely with Partial Large Bowel Obstruction. [PDF]
Zhou Q +5 more
europepmc +1 more source
Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3-4 CKD-results from a placebo-controlled randomized trial. [PDF]
Tiong MK +10 more
europepmc +1 more source
A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case report [PDF]
Michael Smyth, Raymond Pratt
openalex +1 more source
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis [PDF]
Blanca Gros +7 more
openalex +1 more source
Lanthanum carbonate, body lanthanum accumulation and potential liver toxicity [PDF]
Bernard Lacour +3 more
openalex +1 more source
FP803EFFECTS OF NICOTINAMIDE AND LANTHANUM CARBONATE ON SERUM PHOSPHATE AND FGF23 CONCENTRATIONS IN CHRONIC KIDNEY DISEASE: PRIMARY RESULTS OF THE COMBINE TRIAL [PDF]
Joachim H. Ix +12 more
openalex +1 more source

